等待開盤 11-26 09:30:00 美东时间
+0.440
+2.85%
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collaboration
11-10 20:15
(来源:经济日报) 转自:经济日报 随着京东健康11.11进入高潮阶段,海量健康产品迎来年度低价,多重玩法同步上线,为用户带来实实在在的优惠。11月9日晚8点至...
11-10 09:47
服务全球女性的公司被卖了。 在联手收购博士伦失败后,黑石和TPG又盯上了新目标。10月21日,专注全球女性健康的创新型医疗技术公司Hologic(豪洛捷)宣布...
11-08 11:23
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Raymond James analyst Gary Nachman reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and raises the price target from $18 to $19.
10-30 22:32
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Bausch & Lomb (TSX:BLCO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.16 by 12.5 percent. This is a 5.88 percent increase over earnings of $0.17 per share from the same
10-29 18:59
中新经纬10月27日电 (王玉玲)27日,有消息称,诺华与康哲维盛签署战略合作协议,前者将两款眼科产品在中国的独家进口、商业推广和分销权转让给康哲维盛。 ...
10-27 17:01